1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution
Immune Response BioPharma, Inc. Logo

REMUNE Effectiveness Extends Years After Inoculation REMUNE Patient Has 2 Healthy HIV Free Children

REMUNE Effectiveness Extends Years After Inoculation REMUNE Injected Patient Has 2 Healthy HIV Free Children Proving the Vaccine has Strong Immune Responses a Decade Later

 
PRLog - Sep. 25, 2012 - REMUNE Effectiveness Extends Years After Inoculation REMUNE Injected Patient Has 2 Healthy HIV Free Children Proving the Vaccine has Strong Immune Responses a Decade Later.

        Immune Response BioPharma, Inc. Today, Reports that REMUNE Injected patient  has had great success with her recovery since being part of one of the large multi-center Phase III Studies from the year 2000. Nancy Graham a study participant has had two healthy  HIV Free born children born in the years 2004 and 2005, one a beautiful girl named Kayla. She has also reported strong immune responses since receiving the vaccine and has been off of HAART drugs for years and says she has no detectable HIV in her blood.

         This news comes at a time when many had given up on the whole killed method, this particular patient has proven to have a strong immune response to the vaccine and her story can be of benefit to those who are looking for an alternative to the HAART drugs. We are learning from patients who contact IRBP and would like to have access to REMUNE, that stories like Nancy's and others have who have had success with REMUNE can only give those HIV patients hope towards achieving similar results and those who have been skeptical of the whole killed vaccine approach may want to change their opinions of the long term effects REMUNE may have on rebuilding the immune system to fight off the disease.

        "IRBP is very happy to report Nancy's story and hope it gives REMUNE a second look by the scientific and medical community, that the vaccine has merit and can benefit those infected with HIV. The vaccine appears to have long lasting benefits for those who have had the opportunity to be inoculated with the vaccine, this is good news for those who want a real alternative to the toxic drugs and their side effects. While Nancy has been through a tragic ordeal since being infected with the HIV disease, REMUNE has given her almost 13 additional years of life extension since being part of a study in 2000. She has also been through a difficult period of harassment she claims from the researchers and the government over her HIV free births of her two children and wishes not to disclose her current location out of further fear of retaliation. I find the allegations she disclosed to me to be disgusting and reprehensible actions if they are true, including her claims of the government and the researchers wanting to take her children from her to discredit her claims. Nancy should not fear for telling her story and the rule of law will bring those responsible to justice if what she claims is true" Mr. Buswell CEO IRBP.

IRBP plans to move to commercialization of REMUNE once we have partnered NeuroVax and RAVAX for MS and RA respectfully and try to help patients such as Nancy Graham worldwide get access to REMUNE vaccine.

Immune Response BioPharma, Inc. maybe found on the World Wide Web @ www.immuneresponse.net

--- End ---

Click to Share

Contact Email:
***@immuneresponsebiopharma.com Email Verified
Source:Immune Response BioPharma, Inc.
Phone:(917) 275-7931
Zip:10001
City/Town:New York City - New York - United States
Industry:Biotech, Health
Tags:immune response biopharma, inc, REMUNE vaccine, hiv aids, Therapeutic Vaccine
Shortcut:prlog.org/11982962
Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “

More...

Trending News...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
9K2K1K
Click to Share